ClinicalTrials.govpublic full text
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis
ichthyosis, il-36 receptor, interleukin 36, imsidolimab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810130
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.